PF4 ENHANCED assay for the diagnosis of heparin-induced thrombocytopenia in complex medical and surgical patients

Critical Care Medicine

Volumn 35, Issue 7, 2007, Pages 1691-1695

  Shaheed, Gurvinder ^a   Malkovska, Vera ^a   Mendoza, Jose ^a   Patel, Mehool ^a   Rees, John ^a   Wesley, Robert ^b   Merryman, Paula ^b   Horne, McDonald ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Diagnosis; Enzyme linked immunosorbent assay; Heparin; Sensitivity; Thrombocytopenia

Indexed keywords

CARBON 14; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; SEROTONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROTONIN RELEASE; SURGICAL PATIENT; THROMBOCYTOPENIA;

EID: 34250881553     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000268057.62578.3A     Document Type: Article

References (20)

1. Warkentin TE: Heparin-induced thrombocytopenia: Pathogenesis and management. Br J Haematol 2003; 121:535-555
2. Davoren A, Aster RH: Heparin-induced thrombocytopenia and thrombosis. Am J Hematol 2006; 81:36-44
3. Warkentin TE, Roberts RS, Hirsh J, et al: An improved definition of immune heparininduced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003; 163:2518-2524
4. Verma AK, Levine M, Shalansky SJ, et al: Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy 2003; 23:745-753
5. Warkentin TE: Pseudo-heparin-induced thrombocytopenia. In: Heparin-Induced Thrombocytopenia. Third Edition. Warkentin TE, Greinacher A (Eds). New York, Marcel-Dekker, 2004, pp 313-334
6. Napolitano LM, Warkentin TE, AlMahameed A, et al: Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management. Crit Care Med 2006; 34:2898-2911
7. Lo GK, Juhl D, Warkenten TE, et al: Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006; 4:759-765
8. Kottke-Marchant K, Bontempo FA: A positive in vitro assay is required to diagnose heparin-induced thrombocytopenia. Med Clin North Am 2003; 87:1215-1224
9. Francis JL: A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex. Semin Thromb Hemost 2004; 30:359-368
10. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67:27-30
11. Warkentin TE, Sheppard JAI, Horsewood P, et al: Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000; 96:1703-1708
12. Warkentin TE, Sheppard JAI, Moore JC, et al: Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need? J Lab Clin Med 2005; 146:341-346
13. Izban KF, Leitz HW, Hoppensteadt DA, et al: Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparininduced thrombocytopenia. Semin Throb Hemost 1999; 25:51-56
14. Warkentin TE, Greinacher A: Laboratory testing for heparin-induced thrombocytopenia. In: Heparin-Induced Thrombocytopenia. Third Edition. Warkentin TE, Greinacher A (Eds). New York, Marcel-Dekker, 2004, pp 271-311
15. Greinacher A, Amiral J, Dummel V, et al: Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 1994; 34:381-385
16. Pouplard C, Amiral J, Borg JY, et al: Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparininduced thrombocytopenia. Am J Clin Pathol 1999; 111:700-706
17. Amiral J, Marfaing-Koka A, Wolf M, et al: Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 1996; 88:410-416
18. Juhl D, Eichler P, Lubenow N, et al: Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparininduced thrombocytopenia. Eur J Haematol 2006; 76:420-426
19. Refaai MA, Laposata M, Van Cott EM: Clinical significance of a borderline titer in a negative ELISA test for heparin-induced thrombocytopenia. Am J Clin Pathol 2003; 119:61-65
20. Zwicker JI, Uhl L, Huang WY, et al: Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2004; 2:2133-2137